Dr. Ravi Salgia, Innovator at the University of Chicago Medical Center

Ravi Salgia

Professor of Medicine, Pathology and Dermatology; Director, Chest Oncology and Thoracic Oncology Research Program; Vice Chair, Translational Research

Dr. Ravi Salgia isn't content to simply treat cancer. He wants to invent better cancer medicines that don't sicken patients.

Get in touch

Content Contributors


Written By

Edited By

This page features: 11 cited research articles

About Ravi Salgia

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Team Leader icon

    Team Leader

  • 10+ Years of Experience icon

    10+ Years of Experience

  • Board Certified icon

    Board Certified in Medical Oncology

  • Board Certified icon

    Board Certified in Internal Medicine

Luckily, Dr. Ravi Salgia, a medical oncologist, gets to be healer and innovator at the University of Chicago Medical Center (UCMC), a pre-eminent lung cancer center and pioneer in mesothelioma treatment.

As part of UCMC’s Mesothelioma Team and head of both its Chest Oncology Department and Thoracic Oncology Research Program, Salgia is involved in research identifying the biological components of individual cancer cells known as bio-markers that are particularly vulnerable to medicines. These bio-markers could be used someday to help doctors predict who is likely to get cancer or experience a recurrence after treatment.

His research team has also discovered that certain proteins make cancer drugs more potent and learned that the enzyme tyrosine kinase, which turns many cell functions on and off, is an important key to lung cancer treatment.

Ravi Salgia M.D.

If you want to change the world, be that change.’ That’s (a quote) by Mahatma Gandhi, and I think it is what we have designed here at the University of Chicago.”

Salgia is able to conduct his research thanks to the medical center’s prestigious designation as a National Cancer Institute (NCI) Comprehensive Cancer Center, one of only 40 in the nation. As a result, since 1973, UCMC has received continuous NCI funding for cancer research. Of the 363 clinical trials ongoing today, eight concern mesothelioma.

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Salgia and find the treatment that's best for you.

Get Started Today

Pioneers in Mesothelioma Treatment

In addition, UCMC has been pioneering mesothelioma treatment for 20 years with a team of chemotherapy and radiation experts, as well as nurses, scientists and imaging specialists.

Quick Fact:

Dr. Salgia is fluent in Hindi and Spanish.

Salgia said in his lecture that the medical center’s research focus benefits patients in a personal way. Thanks to its research, patients often are spared many side-effects of cancer treatment. For example, years ago UCMC studied the chemotherapy drug pemetrexed as a new treatment for mesothelioma that didn’t cause hair loss, he said. Today it is now being tested as a lung cancer treatment.

“It was also figured out here, actually very intelligently, that you needed to supplement our patients with vitamins, like B-12 as well as folic acid, to have the maximal effect of the chemotherapy and have the minimal effect of the toxicity from this therapy itself.”

Both a board-certified medical oncologist and internist, Salgia has been practicing medicine since 1987.

See More Top Mesothelioma Doctors


Salgia has written over 160 scholarly articles, nine of which discuss mesothelioma. The most recent, which explains the endothelial growth factor receptor in malignant pleural mesothelioma, was published in 2011 in Journal of Carcinogenesis.

Disclaimer: Dr. Ravi Salgia has no professional affiliation with Asbestos.com.

Ravi Salgia
Get Help Contacting Ravi Salgia

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get the Best Treatment Options

Find a Doctor
Asbestos.com Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Share this article

Last Modified November 16, 2018

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by

7 Cited Article Sources


Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

On This Page

Content Contributors

Share Our Page

Free Wristbands

Help Spread Mesothelioma Awareness

Mesothelioma Wristbands Get a wristband
Get Your Free Mesothelioma Guide Chat live with a patient advocate now loading spinner